APO Research

APO RESEARCH · REPORT

NK Cell Cytotoxicity Assay Service

Selected research

Market Structure

Global NK Cell Cytotoxicity Assay Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global NK Cell Cytotoxicity Assay Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NK Cell Cytotoxicity Assay Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NK Cell Cytotoxicity Assay Service include Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, Imodels and Xeno Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global NK Cell Cytotoxicity Assay Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NK Cell Cytotoxicity Assay Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NK Cell Cytotoxicity Assay Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the NK Cell Cytotoxicity Assay Service market size, projected growth trends, production technologies, key applications, and end-use industries.

NK Cell Cytotoxicity Assay Service Segment by Company

Reaction Biology

Axion BioSystems

Sartorius

ICE Bioscience

Shanghai Saily Biotechnology

ProBio

Charles River

Imodels

Xeno Diagnostics

Cyagen

MarinBio

Pharmalegacy

Celentyx

Crown Bioscience

Cellomatics Biosciences

Agilent

Laboratories

Explicyte

NK Cell Cytotoxicity Assay Service Segment by Type

LDH (Lactate Dehydrogenase) Release Method

51Cr Release Method

Flow Cytometry Detection

Other

NK Cell Cytotoxicity Assay Service Segment by Application

Cancer Research

Infectious Disease Research

Immunotherapy Development

NK Cell Cytotoxicity Assay Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Cytotoxicity Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cell Cytotoxicity Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Cytotoxicity Assay Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of NK Cell Cytotoxicity Assay Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NK Cell Cytotoxicity Assay Service industry.

Chapter 3: Detailed analysis of NK Cell Cytotoxicity Assay Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NK Cell Cytotoxicity Assay Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of LDH (Lactate Dehydrogenase) Release Method Table 3. Key Players of 51Cr Release Method Table 4. Key Players of Flow Cytometry Detection Table 3. Key Players of Other Table 4. Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Research Table 6. Key Players of Infectious Disease Research Table 7. Key Players of Immunotherapy Development Table 8. Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global NK Cell Cytotoxicity Assay Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global NK Cell Cytotoxicity Assay Service Market Share by Region (2021-2026) Table 11. Global NK Cell Cytotoxicity Assay Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global NK Cell Cytotoxicity Assay Service Market Share by Region (2027-2032) Table 13. NK Cell Cytotoxicity Assay Service Industry Trends Table 14. NK Cell Cytotoxicity Assay Service Industry Drivers Table 15. NK Cell Cytotoxicity Assay Service Industry Opportunities and Challenges Table 16. NK Cell Cytotoxicity Assay Service Industry Restraints Table 17. Global NK Cell Cytotoxicity Assay Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Company (2021-2026) Table 19. Global NK Cell Cytotoxicity Assay Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global NK Cell Cytotoxicity Assay Service Key Company Head Office and Area Served Table 21. Global NK Cell Cytotoxicity Assay Service Company, Product Type & Application Table 22. Global NK Cell Cytotoxicity Assay Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global NK Cell Cytotoxicity Assay Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global NK Cell Cytotoxicity Assay Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Type (2021-2026) Table 29. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Type (2027-2032) Table 30. Global NK Cell Cytotoxicity Assay Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Application (2021-2026) Table 34. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Application (2027-2032) Table 35. Reaction Biology Company Information Table 36. Reaction Biology Business Overview Table 37. Reaction Biology NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Reaction Biology NK Cell Cytotoxicity Assay Service Product Portfolio Table 39. Reaction Biology Recent Development Table 40. Axion BioSystems Company Information Table 41. Axion BioSystems Business Overview Table 42. Axion BioSystems NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Axion BioSystems NK Cell Cytotoxicity Assay Service Product Portfolio Table 44. Axion BioSystems Recent Development Table 45. Sartorius Company Information Table 46. Sartorius Business Overview Table 47. Sartorius NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sartorius NK Cell Cytotoxicity Assay Service Product Portfolio Table 49. Sartorius Recent Development Table 50. ICE Bioscience Company Information Table 51. ICE Bioscience Business Overview Table 52. ICE Bioscience NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. ICE Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio Table 54. ICE Bioscience Recent Development Table 55. Shanghai Saily Biotechnology Company Information Table 56. Shanghai Saily Biotechnology Business Overview Table 57. Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Product Portfolio Table 59. Shanghai Saily Biotechnology Recent Development Table 60. ProBio Company Information Table 61. ProBio Business Overview Table 62. ProBio NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ProBio NK Cell Cytotoxicity Assay Service Product Portfolio Table 64. ProBio Recent Development Table 65. Charles River Company Information Table 66. Charles River Business Overview Table 67. Charles River NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Charles River NK Cell Cytotoxicity Assay Service Product Portfolio Table 69. Charles River Recent Development Table 70. Imodels Company Information Table 71. Imodels Business Overview Table 72. Imodels NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Imodels NK Cell Cytotoxicity Assay Service Product Portfolio Table 74. Imodels Recent Development Table 75. Xeno Diagnostics Company Information Table 76. Xeno Diagnostics Business Overview Table 77. Xeno Diagnostics NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Xeno Diagnostics NK Cell Cytotoxicity Assay Service Product Portfolio Table 79. Xeno Diagnostics Recent Development Table 80. Cyagen Company Information Table 81. Cyagen Business Overview Table 82. Cyagen NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Cyagen NK Cell Cytotoxicity Assay Service Product Portfolio Table 84. Cyagen Recent Development Table 85. MarinBio Company Information Table 86. MarinBio Business Overview Table 87. MarinBio NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. MarinBio NK Cell Cytotoxicity Assay Service Product Portfolio Table 89. MarinBio Recent Development Table 90. Pharmalegacy Company Information Table 91. Pharmalegacy Business Overview Table 92. Pharmalegacy NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Pharmalegacy NK Cell Cytotoxicity Assay Service Product Portfolio Table 94. Pharmalegacy Recent Development Table 95. Celentyx Company Information Table 96. Celentyx Business Overview Table 97. Celentyx NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Celentyx NK Cell Cytotoxicity Assay Service Product Portfolio Table 99. Celentyx Recent Development Table 100. Crown Bioscience Company Information Table 101. Crown Bioscience Business Overview Table 102. Crown Bioscience NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Crown Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio Table 104. Crown Bioscience Recent Development Table 105. Cellomatics Biosciences Company Information Table 106. Cellomatics Biosciences Business Overview Table 107. Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Product Portfolio Table 109. Cellomatics Biosciences Recent Development Table 110. Agilent Company Information Table 111. Agilent Business Overview Table 112. Agilent NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Agilent NK Cell Cytotoxicity Assay Service Product Portfolio Table 114. Agilent Recent Development Table 115. Laboratories Company Information Table 116. Laboratories Business Overview Table 117. Laboratories NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Laboratories NK Cell Cytotoxicity Assay Service Product Portfolio Table 119. Laboratories Recent Development Table 120. Explicyte Company Information Table 121. Explicyte Business Overview Table 122. Explicyte NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Explicyte NK Cell Cytotoxicity Assay Service Product Portfolio Table 124. Explicyte Recent Development Table 125. North America NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026) & (US$ Million) Table 126. North America NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032) & (US$ Million) Table 127. North America NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026) & (US$ Million) Table 128. North America NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032) & (US$ Million) Table 129. North America NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026) Table 131. North America NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032) Table 132. Europe NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026) Table 138. Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032) Table 139. China NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026) & (US$ Million) Table 140. China NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032) & (US$ Million) Table 141. China NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026) & (US$ Million) Table 142. China NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026) Table 149. Asia NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. NK Cell Cytotoxicity Assay Service Product Image Figure 2. Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global NK Cell Cytotoxicity Assay Service Market Share by Type: 2025 VS 2032 Figure 4. LDH (Lactate Dehydrogenase) Release Method Image Figure 5. 51Cr Release Method Image Figure 6. Flow Cytometry Detection Image Figure 7. Other Image Figure 8. Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global NK Cell Cytotoxicity Assay Service Market Share by Application: 2025 VS 2032 Figure 10. Cancer Research Image Figure 11. Infectious Disease Research Image Figure 12. Immunotherapy Development Image Figure 13. Global NK Cell Cytotoxicity Assay Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 15. Global NK Cell Cytotoxicity Assay Service Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global NK Cell Cytotoxicity Assay Service Market Share by Players in 2025 Figure 18. Global Top 5 and 10 NK Cell Cytotoxicity Assay Service Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global NK Cell Cytotoxicity Assay Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Type (2021-2032) Figure 22. Global NK Cell Cytotoxicity Assay Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global NK Cell Cytotoxicity Assay Service Revenue Market Share by Application (2021-2032) Figure 24. North America NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 25. North America NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032) Figure 26. North America NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032) Figure 27. North America NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032) Figure 28. United States NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 29. Canada NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 30. Mexico NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032) Figure 33. Europe NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032) Figure 34. Europe NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032) Figure 35. Germany NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 36. France NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 37. U.K. NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 38. Italy NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 39. Russia NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 41. China NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 42. China NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032) Figure 43. China NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032) Figure 44. Asia NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 45. Asia NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032) Figure 46. Asia NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032) Figure 47. Asia NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032) Figure 48. Japan NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 49. South Korea NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 52. India NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 53. Australia NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032) Figure 58. Brazil NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 59. South Africa NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 61. Turkey NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 62. Argentina NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 63. UAE NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 64. Egypt NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 65. Chile NK Cell Cytotoxicity Assay Service Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • LDH (Lactate Dehydrogenase) Release Method
  • 51Cr Release Method
  • Flow Cytometry Detection
  • Other
Applications
  • Cancer Research
  • Infectious Disease Research
  • Immunotherapy Development
Companies covered
  • Reaction Biology
  • Axion BioSystems
  • Sartorius
  • ICE Bioscience
  • Shanghai Saily Biotechnology
  • ProBio
  • Charles River
  • Imodels
  • Xeno Diagnostics
  • Cyagen
  • MarinBio
  • Pharmalegacy
  • Celentyx
  • Crown Bioscience
  • Cellomatics Biosciences
  • Agilent
  • Laboratories
  • Explicyte

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 LDH (Lactate Dehydrogenase) Release Method
  5. 1.2.3 51Cr Release Method
  6. 1.2.4 Flow Cytometry Detection
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global NK Cell Cytotoxicity Assay Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Cancer Research
  11. 1.3.3 Infectious Disease Research
  12. 1.3.4 Immunotherapy Development
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global NK Cell Cytotoxicity Assay Service Growth Trends by Region
  15. 1.5.1 Global NK Cell Cytotoxicity Assay Service Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 NK Cell Cytotoxicity Assay Service Market Size by Region (2021-2026)
  17. 1.5.3 NK Cell Cytotoxicity Assay Service Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global NK Cell Cytotoxicity Assay Service Market Dynamics
  1. 2.1 NK Cell Cytotoxicity Assay Service Industry Trends
  2. 2.2 NK Cell Cytotoxicity Assay Service Industry Drivers
  3. 2.3 NK Cell Cytotoxicity Assay Service Industry Opportunities and Challenges
  4. 2.4 NK Cell Cytotoxicity Assay Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global NK Cell Cytotoxicity Assay Service Revenue by Company (2021-2026)
  2. 3.2 Global NK Cell Cytotoxicity Assay Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global NK Cell Cytotoxicity Assay Service Key Company Head office and Area Served
  4. 3.4 Global NK Cell Cytotoxicity Assay Service Company, Product Type & Application
  5. 3.5 Global NK Cell Cytotoxicity Assay Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global NK Cell Cytotoxicity Assay Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 NK Cell Cytotoxicity Assay Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 NK Cell Cytotoxicity Assay Service Tier 1, Tier 2, and Tier 3
4 NK Cell Cytotoxicity Assay Service Market by Type
  1. 4.1 Global NK Cell Cytotoxicity Assay Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2032)
  3. 4.3 Global NK Cell Cytotoxicity Assay Service Market Size Share by Type (2021-2032)
5 NK Cell Cytotoxicity Assay Service Market by Application
  1. 5.1 Global NK Cell Cytotoxicity Assay Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2032)
  3. 5.3 Global NK Cell Cytotoxicity Assay Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Reaction Biology
  2. 6.1.1 Reaction Biology Company Information
  3. 6.1.2 Reaction Biology Business Overview
  4. 6.1.3 Reaction Biology NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Reaction Biology NK Cell Cytotoxicity Assay Service Product Portfolio
  6. 6.1.5 Reaction Biology Recent Developments
  7. 6.2 Axion BioSystems
  8. 6.2.1 Axion BioSystems Company Information
  9. 6.2.2 Axion BioSystems Business Overview
  10. 6.2.3 Axion BioSystems NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Axion BioSystems NK Cell Cytotoxicity Assay Service Product Portfolio
  12. 6.2.5 Axion BioSystems Recent Developments
  13. 6.3 Sartorius
  14. 6.3.1 Sartorius Company Information
  15. 6.3.2 Sartorius Business Overview
  16. 6.3.3 Sartorius NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sartorius NK Cell Cytotoxicity Assay Service Product Portfolio
  18. 6.3.5 Sartorius Recent Developments
  19. 6.4 ICE Bioscience
  20. 6.4.1 ICE Bioscience Company Information
  21. 6.4.2 ICE Bioscience Business Overview
  22. 6.4.3 ICE Bioscience NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ICE Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio
  24. 6.4.5 ICE Bioscience Recent Developments
  25. 6.5 Shanghai Saily Biotechnology
  26. 6.5.1 Shanghai Saily Biotechnology Company Information
  27. 6.5.2 Shanghai Saily Biotechnology Business Overview
  28. 6.5.3 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Product Portfolio
  30. 6.5.5 Shanghai Saily Biotechnology Recent Developments
  31. 6.6 ProBio
  32. 6.6.1 ProBio Company Information
  33. 6.6.2 ProBio Business Overview
  34. 6.6.3 ProBio NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 ProBio NK Cell Cytotoxicity Assay Service Product Portfolio
  36. 6.6.5 ProBio Recent Developments
  37. 6.7 Charles River
  38. 6.7.1 Charles River Company Information
  39. 6.7.2 Charles River Business Overview
  40. 6.7.3 Charles River NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Charles River NK Cell Cytotoxicity Assay Service Product Portfolio
  42. 6.7.5 Charles River Recent Developments
  43. 6.8 Imodels
  44. 6.8.1 Imodels Company Information
  45. 6.8.2 Imodels Business Overview
  46. 6.8.3 Imodels NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Imodels NK Cell Cytotoxicity Assay Service Product Portfolio
  48. 6.8.5 Imodels Recent Developments
  49. 6.9 Xeno Diagnostics
  50. 6.9.1 Xeno Diagnostics Company Information
  51. 6.9.2 Xeno Diagnostics Business Overview
  52. 6.9.3 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Product Portfolio
  54. 6.9.5 Xeno Diagnostics Recent Developments
  55. 6.10 Cyagen
  56. 6.10.1 Cyagen Company Information
  57. 6.10.2 Cyagen Business Overview
  58. 6.10.3 Cyagen NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Cyagen NK Cell Cytotoxicity Assay Service Product Portfolio
  60. 6.10.5 Cyagen Recent Developments
  61. 6.11 MarinBio
  62. 6.11.1 MarinBio Company Information
  63. 6.11.2 MarinBio Business Overview
  64. 6.11.3 MarinBio NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 MarinBio NK Cell Cytotoxicity Assay Service Product Portfolio
  66. 6.11.5 MarinBio Recent Developments
  67. 6.12 Pharmalegacy
  68. 6.12.1 Pharmalegacy Company Information
  69. 6.12.2 Pharmalegacy Business Overview
  70. 6.12.3 Pharmalegacy NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Pharmalegacy NK Cell Cytotoxicity Assay Service Product Portfolio
  72. 6.12.5 Pharmalegacy Recent Developments
  73. 6.13 Celentyx
  74. 6.13.1 Celentyx Company Information
  75. 6.13.2 Celentyx Business Overview
  76. 6.13.3 Celentyx NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Celentyx NK Cell Cytotoxicity Assay Service Product Portfolio
  78. 6.13.5 Celentyx Recent Developments
  79. 6.14 Crown Bioscience
  80. 6.14.1 Crown Bioscience Company Information
  81. 6.14.2 Crown Bioscience Business Overview
  82. 6.14.3 Crown Bioscience NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Crown Bioscience NK Cell Cytotoxicity Assay Service Product Portfolio
  84. 6.14.5 Crown Bioscience Recent Developments
  85. 6.15 Cellomatics Biosciences
  86. 6.15.1 Cellomatics Biosciences Company Information
  87. 6.15.2 Cellomatics Biosciences Business Overview
  88. 6.15.3 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Product Portfolio
  90. 6.15.5 Cellomatics Biosciences Recent Developments
  91. 6.16 Agilent
  92. 6.16.1 Agilent Company Information
  93. 6.16.2 Agilent Business Overview
  94. 6.16.3 Agilent NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Agilent NK Cell Cytotoxicity Assay Service Product Portfolio
  96. 6.16.5 Agilent Recent Developments
  97. 6.17 Laboratories
  98. 6.17.1 Laboratories Company Information
  99. 6.17.2 Laboratories Business Overview
  100. 6.17.3 Laboratories NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Laboratories NK Cell Cytotoxicity Assay Service Product Portfolio
  102. 6.17.5 Laboratories Recent Developments
  103. 6.18 Explicyte
  104. 6.18.1 Explicyte Company Information
  105. 6.18.2 Explicyte Business Overview
  106. 6.18.3 Explicyte NK Cell Cytotoxicity Assay Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Explicyte NK Cell Cytotoxicity Assay Service Product Portfolio
  108. 6.18.5 Explicyte Recent Developments
7 North America
  1. 7.1 North America NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
  2. 7.2 North America NK Cell Cytotoxicity Assay Service Market Size by Type
  3. 7.2.1 North America NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026)
  4. 7.2.2 North America NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032)
  5. 7.2.3 North America NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032)
  6. 7.3 North America NK Cell Cytotoxicity Assay Service Market Size by Application
  7. 7.3.1 North America NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026)
  8. 7.3.2 North America NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032)
  9. 7.3.3 North America NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032)
  10. 7.4 North America NK Cell Cytotoxicity Assay Service Market Size by Country
  11. 7.4.1 North America NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
  13. 7.4.3 North America NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032)
  14. 7.4.4 North America NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
  2. 8.2 Europe NK Cell Cytotoxicity Assay Service Market Size by Type
  3. 8.2.1 Europe NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032)
  6. 8.3 Europe NK Cell Cytotoxicity Assay Service Market Size by Application
  7. 8.3.1 Europe NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032)
  10. 8.4 Europe NK Cell Cytotoxicity Assay Service Market Size by Country
  11. 8.4.1 Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
  2. 9.2 China NK Cell Cytotoxicity Assay Service Market Size by Type
  3. 9.2.1 China NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026)
  4. 9.2.2 China NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032)
  5. 9.2.3 China NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032)
  6. 9.3 China NK Cell Cytotoxicity Assay Service Market Size by Application
  7. 9.3.1 China NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026)
  8. 9.3.2 China NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032)
  9. 9.3.3 China NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
  2. 10.2 Asia NK Cell Cytotoxicity Assay Service Market Size by Type
  3. 10.2.1 Asia NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032)
  6. 10.3 Asia NK Cell Cytotoxicity Assay Service Market Size by Application
  7. 10.3.1 Asia NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032)
  10. 10.4 Asia NK Cell Cytotoxicity Assay Service Market Size by Country
  11. 10.4.1 Asia NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa NK Cell Cytotoxicity Assay Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research